Hexagon Nutrition Board Approves Q1 FY27 Results, Recommends Dividend, and Appoints Directors
Hexagon Nutrition approved Q1 FY27 results and recommended a final dividend of ₹0.30 per share. The AGM is on September 22, 2026. Key director remuneration was revised, and Mr. Raghunath Sawant was appointed Additional Executive Director. The company reported total income of ₹1,063.84 million and a net profit of ₹80.73 million for the quarter ended June 30, 2026.
The dividend recommendation and director appointments are significant corporate actions that can influence investor confidence and company direction. Approval of financial results is routine but important for transparency.
The company announced positive outcomes including approval of financial results, recommendation of a dividend, and key appointments, indicating stable governance and operational progress.
Hexagon Nutrition Limited's Board of Directors convened on August 12, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board also recommended a final dividend of ₹0.30 per equity share for the financial year ended March 31, 2026. The record date for this dividend is fixed as September 15, 2026. The 33rd Annual General Meeting (AGM) is scheduled for September 22, 2026, to be held via Video Conferencing/Other Audio-Visual Means. Book closure for the AGM will be from September 16 to September 22, 2026. Additionally, the Board approved revisions to the annual remuneration of key directors, including Mr. Arun Purushottam Kelkar (Chairman and Executive Director), Mr. Vikram Arun Kelkar (Managing Director), and Dr. Nikhil Arun Kelkar (Joint Managing Director), subject to member approval. Mr. Arun Purushottam Kelkar's reappointment as Chairman & Director was also recommended. Mr. Raghunath Sawant has been appointed as an Additional Executive Director effective August 12, 2026. The Articles of Association will be altered, subject to member approval. The IPO Committee has been dissolved following the successful completion of the IPO. The trading window will open 48 hours after the declaration of financial results for the quarter ended June 30, 2026.
The company reported total income of ₹1,063.84 million for the quarter ended June 30, 2026, with a net profit of ₹80.73 million. For the same period, total comprehensive income stood at ₹84.34 million. Revenue from operations for the quarter was ₹1,043.06 million. The unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, were approved, along with the Limited Review Report from the Statutory Auditors. The financial results will be published in newspapers along with a QR code linking to the complete financial results on the company's webpage.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.